Nasoferm nasal spray

Nasoferm is a well-known nasal spray used primarily for the short-term treatment of nasal congestion during colds. The brand belongs to the pharmaceutical portfolio originally developed in the Nordic and European markets to provide effective relief through the active ingredient xylometazoline.

The brand is currently owned by STADA Arzneimittel AG, a major German pharmaceutical company. STADA acquired various brands, including Nasoferm, from GSK (GlaxoSmithKline) as part of a strategic expansion of their consumer healthcare business. While the brand has strong roots in the Nordic region, its production typically occurs in high-quality pharmaceutical manufacturing sites across Europe, notably in Switzerland and Germany, ensuring strict adherence to medical standards. STADA continues to manage the brand globally, focusing on accessible self-care treatments.